Rivaroxaban for thromboprophylaxis in a patient receiving electroconvulsive therapy.

Shuman, Michael; Hieber, Robin; Moss, Lori; Patel, Dimple

Shuman, Michael; Hieber, Robin; Moss, Lori; Patel, Dimple.

Affiliation

Shuman M; Captain James A. Lovell Federal Health Care Center North Chicago, IL and Department of Pharmacy Practice College of Pharmacy Rosalind Franklin University North Chicago, IL Michael.Shuman@rosalindfranklin.edu Captain James A. Lovell Federal Health Care Center North Chicago, IL and Department of Pharmacy Practice Chicago College of Pharmacy Midwestern University Downers Grove, IL Captain James A. Lovell Federal Health Care Center North Chicago, IL and Department of Psychiatry and Behavioral Scienc

J ECT ; 31(1): e19-20, 2015 Mar.

Article in En | MEDLINE | ID: mdl-25587812

Subject(s)

Atrial Fibrillation/drug therapy; Bipolar Disorder/therapy; Electroconvulsive Therapy/adverse effects; Factor Xa Inhibitors/therapeutic use; Rivaroxaban/therapeutic use; Thrombosis/prevention & control; Atrial Fibrillation/complications; Bipolar Disorder/complications; Electroconvulsive Therapy/methods; Humans; Male; Middle Aged; Thrombosis/etiology

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atrial Fibrillation / Thrombosis / Bipolar Disorder / Electroconvulsive Therapy / Factor Xa Inhibitors / Rivaroxaban Type of study: Etiology_studies Limits: Humans / Male / Middle aged Language: En Journal: J ECT Journal subject: MEDICINA Year: 2015 Type: Article

Fulltext

XML

PubMed Links

Search on Google